Aurora Cannabis to Review Takeover Bid From Rival Curaleaf - WSJ
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Curaleaf has plotted a $272 million hostile takeover of Aurora Cannabis, a US multi-state operator targeting its Canadian rival in a deal framed as potentially reshaping the global cannabis market.
- Aurora Cannabis is reviewing the unsolicited takeover bid from rival Curaleaf, while Tilray Brands stock rose on the news of the sector consolidation move.
Why it matters: A hostile bid of $272 million in cannabis is rare and signals aggressive consolidation pressure on Aurora Cannabis shareholders, who must now weigh a takeover offer against the company's independent path; the immediate Tilray Brands stock rally shows the market is pricing in broader sector M&A as a likely outcome.
Ask SkimNews
